| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |